LCM
INO icon

Landscape Capital Management’s Inovio Pharmaceuticals INO Stock Holding History

Landscape Capital Management’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,066
Closed -$86K – 687
2015
Q4 		$86K Buy
+1,066
New +$84.9K 0.01% 949
2014
Q4 		– Sell
-3,875
Closed -$458K – 552
2014
Q3 		$458K Buy
+3,875
New +$483K 0.32% 85

Other funds holding INO

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SIP
Stoneridge Investment Partners Radnor, Pennsylvania $138M AUM 7.66% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Landscape Capital Management's INO Position: Q1 2016 in Review

Landscape Capital Management sold out of Inovio Pharmaceuticals (INO) in Q1 2016, closing a stake of 1,066 shares — an estimated $86K sold.

Landscape Capital Management first reported a position in INO in Q3 2014 and held it in 2 quarters. The position peaked at $458K in Q3 2014. 115 funds tracked by Wall St. Rank hold INO as of Q1 2016.

  • Landscape Capital Management reported no remaining Inovio Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Landscape Capital Management sold 1,066 Inovio Pharmaceuticals shares in Q1 2016, an estimated $86K.
  • Landscape Capital Management first reported a position in Inovio Pharmaceuticals in Q3 2014 and held it in 2 quarters.
  • Landscape Capital Management's Inovio Pharmaceuticals position peaked at $458K in Q3 2014.
  • 115 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2016.

Based on Landscape Capital Management's 13F filing for Q1 2016, filed 11 May 2016.